Left ventricular contractile performance and heart failure in patients with left ventricular ejection fraction more than 40.
Aged
Cardiac Catheterization
/ instrumentation
Cardiac Catheters
Female
Heart Failure
/ diagnosis
Hospitalization
Humans
Male
Myocardial Contraction
Predictive Value of Tests
Prognosis
Retrospective Studies
Stroke Volume
Transducers, Pressure
Ventricular Dysfunction, Left
/ diagnosis
Ventricular Function, Left
Ventricular Pressure
Heart failure
Inertia force of late-systolic aortic flow
Mid-range LVEF
Systolic dysfunction
Journal
Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
25
04
2020
accepted:
29
05
2020
pubmed:
7
6
2020
medline:
15
12
2020
entrez:
7
6
2020
Statut:
ppublish
Résumé
Heart failure (HF) with mid-range left ventricular ejection fraction (LVEF) (HFmrEF) is considered a new category of HF and LVEF < 50%, which is the upper threshold of LVEF for HFmrEF, is thought to represent a mild decrease in LV contractile performance. We aimed to consider an LVEF threshold value to be taken as a surrogate for impairment of LV contractile performance, resulting in new-onset HF. We enrolled 398 patients with LVEF ≥ 40% that underwent cardiac catheterization. Using the LV pressure recording with a catheter-tipped micromanometer, we calculated the inertia force of late systolic aortic flow (IFLSAF), which was sensitive to the slight impairment in LV contractile performance. We evaluated the utility of the IFLSAF for predicting future cardiovascular death or hospitalization for HF. We performed a receiver operating characteristic (ROC) curve analysis to determine the best LVEF threshold value for distinguishing whether the LV maintained the IFLSAF. A multivariate Cox proportional-hazards model revealed that the loss of IFLSAF was significantly associated with the future adverse events (HR: 7.798, 95%CI 2.174-27.969, p = 0.002). According to the ROC curve analysis, an LVEF ≥ 58% indicated that the LV could maintain the IFLSAF. We concluded that the loss of IFLSAF, which could reflect even slight impairment in LV contractile performance, was a reliable indicator for new-onset HF in patients with LVEF ≥ 40%. LVEF ≥ 58% could be taken as a surrogate for the IFLSAF maintenance; this threshold could be useful for risk stratification of new-onset HF in patients with preserved LVEF.
Identifiants
pubmed: 32504319
doi: 10.1007/s00380-020-01641-w
pii: 10.1007/s00380-020-01641-w
pmc: PMC7595999
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1689-1698Références
Circulation. 2012 Dec 4;126(23):2713-9
pubmed: 23124035
N Engl J Med. 2014 Apr 10;370(15):1383-92
pubmed: 24716680
Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H501-12
pubmed: 16014610
Int J Cardiol. 2006 Apr 4;108(2):181-8
pubmed: 15922464
N Engl J Med. 2019 Oct 24;381(17):1609-1620
pubmed: 31475794
ESC Heart Fail. 2018 Feb;5(1):36-45
pubmed: 28941144
Circ J. 2015;79(10):2209-15
pubmed: 26227392
Cardiovasc Res. 1997 Feb;33(2):433-46
pubmed: 9074709
Circulation. 2013 Oct 15;128(16):e240-327
pubmed: 23741058
J Am Coll Cardiol. 2007 Aug 21;50(8):768-77
pubmed: 17707182
Circulation. 1958 Dec;18(6):1105-17
pubmed: 13608839
Open Heart. 2017 Sep 25;4(2):e000630
pubmed: 29018535
Circulation. 2015 Aug 4;132(5):402-14
pubmed: 26130119
J Am Soc Echocardiogr. 2005 Oct;18(10):1051-7
pubmed: 16198882
Clin Sci (Lond). 2004 Jan;106(1):53-60
pubmed: 12924982
J Am Coll Cardiol. 2006 Sep 5;48(5):983-91
pubmed: 16949491
J Clin Invest. 1976 Sep;58(3):751-60
pubmed: 956400
Eur Heart J. 2016 Feb 1;37(5):455-62
pubmed: 26374849
Circ Heart Fail. 2011 Jan;4(1):27-35
pubmed: 21068341
J Card Fail. 2016 Oct;22(10):763-8
pubmed: 27038640
Eur Heart J. 2020 Mar 21;41(12):1249-1257
pubmed: 31386109
Heart Vessels. 2016 May;31(5):734-43
pubmed: 25771802
Circulation. 2003 Aug 26;108(8):977-82
pubmed: 12912813
Am J Cardiol. 2012 Feb 1;109(3):383-9
pubmed: 22112740
Am J Cardiol. 1986 Feb 15;57(6):450-8
pubmed: 2936235
Eur Heart J. 2012 Jul;33(14):1787-847
pubmed: 22611136
Biometrics. 2000 Jun;56(2):337-44
pubmed: 10877287
JACC Heart Fail. 2016 Jun;4(6):502-10
pubmed: 27256754
Echocardiography. 2011 Jul;28(6):649-57
pubmed: 21676016
Circulation. 2006 Mar 28;113(12):1597-604
pubmed: 16567580